Institutional Biosafety Committee
The formation of an Institutional Biosafety Committee (IBC) at any institution conducting research with recombinant or synthetic nucleic acids is mandated by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (Guidelines). At Northwestern University, the IBC receives its authority from the President of Northwestern and is further charged with review, approval, and oversight of all research protocols involving the use of biohazardous materials. Thus, the purview of the IBC includes research involving recombinant and synthetic nucleic acids as well as agents infectious or harmful to humans, animals, and/or plants (regardless of the presence of recombinant or synthetic nucleic acids), and other genetically altered organisms and agents.
IBC Meeting Schedule
The IBC meets monthly at 11:30 a.m. These meetings are open to members of the NU community. Anyone wishing to attend an IBC meeting should contact Iwona Spath at firstname.lastname@example.org.
|12/13/23 (Adjusted for Winter Recess)
Prior to submission, a registration must be completed and all answers provided as requested. Should there be a need to consult, Iwona Spath or Dr. Rob Foreman can be contacted for help at 1-5581 (Evanston) or 3-0124 (Chicago).